Target intelligence / Profile preview

Heterochromatin protein 1-binding protein 3 (HP1BP3)

Target
HP1BP3
Molecular classification
Linker histone family protein, Chromatin-binding protein, Nuclear structural protein, Other
01

Overview

Heterochromatin protein 1-binding protein 3 (HP1BP3) is a ubiquitously expressed nuclear protein in vertebrates. Structurally, it is evolutionarily related to the linker histone H1, containing three globular DNA-binding domains and a highly basic C-terminal region that promote chromatin compaction[1][2]. HP1BP3 specifically binds heterochromatin protein 1 (HP1) through a conserved HP1-binding motif and is enriched in heterochromatic regions of the nucleus. Functionally, HP1BP3 plays non-redundant roles in maintaining chromatin architecture, regulating gene expression, and advancing cell cycle progression by sustaining heterochromatin integrity. Additionally, it is involved in primary microRNA processing via association with the microprocessor complex[2]. Loss of HP1BP3 disrupts gene expression and leads to fatal developmental defects and chronic growth retardation, underscoring its essential functions for vertebrate survival and growth[1]. There are currently no drugs, established mechanisms of drug action, or validated biomarkers directly associated with HP1BP3. While HP1BP3 is crucial for chromatin structure and cell viability, it is not considered a classic therapeutic target (such as a receptor, enzyme, or transporter). No literature implicates HP1BP3 directly in major human diseases such as cancer or neurodegeneration, though it is indispensable for normal development and physiology[1][2].

Other names
Heterochromatin protein 1 binding protein 3HP1-BP74Protein HP1-BP74HP1BP74
02

Biological functions

Chromatin architecture regulationGene expression modulationHeterochromatin integrity maintenanceCell cycle progression regulation (notably G1-to-S transition)Cellular proliferation controlCo-transcriptional processing of primary microRNAs (pri-miRNA)
03

Disease associations

Other (essential for survival and postnatal growth, but no direct links to major diseases such as cancer, inflammation, or neurodegeneration described)
04

Safety considerations

Potential lethality: HP1BP3 knockout in mice results in high postnatal mortality and growth retardation[1]

Beyond the preview

Go deeper on Heterochromatin protein 1-binding protein 3 (HP1BP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterochromatin protein 1-binding protein 3 (HP1BP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call